Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Ponstan CMI 27 May 2020
Zinforo PI 27 May 2020
Janumet PI 27 May 2020
Estalis Continuous PI 27 May 2020
Revestive CMI 27 May 2020

New products

Product name Type Date released
DBL Flucloxacillin Sodium CMI 27 May 2020
Rozlytrek CMI 27 May 2020
Rozlytrek PI 27 May 2020
DBL Flucloxacillin Sodium PI 25 May 2020
Rixadone Oral PI 25 May 2020